-
(1S,2R,10R,11S,14R,15S)-14-ethynyl-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
-
ChemBase ID:
598
-
Molecular Formular:
C20H26O2
-
Molecular Mass:
298.41924
-
Monoisotopic Mass:
298.19328007
-
SMILES and InChIs
SMILES:
O[C@@]1([C@@]2([C@H]([C@H]3[C@H](CC2)[C@@H]2C(=CC(=O)CC2)CC3)CC1)C)C#C
Canonical SMILES:
C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@H]12
InChI:
InChI=1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18,22H,4-11H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1
InChIKey:
VIKNJXKGJWUCNN-XGXHKTLJSA-N
-
Cite this record
CBID:598 http://www.chembase.cn/molecule-598.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(1S,2R,10R,11S,14R,15S)-14-ethynyl-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
|
(1S,2R,10R,11S,14R,15S)-14-ethynyl-14-hydroxy-15-methyltetracyclo[8.7.0.02,7.011,15]heptadec-6-en-5-one
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Anhydrohydroxynorprogesterone
|
Anovulatorio
|
Anovule
|
Aygestin
|
Binovum
|
Brevicon
|
Brevinor
|
Brevinor 21
|
Brevinor 28
|
Brevinor-1 21
|
Brevinor-1 28
|
Camila
|
Ciclovulan
|
Conceplan
|
Conludaf
|
Conludag
|
Demulen
|
ENT
|
Errin
|
Estrinor
|
Ethinylnortestosterone
|
Ethynylmortestosterone
|
Ethynylnortestosterone
|
Gencept
|
Genora
|
Gestest
|
Jenest
|
Jenest-28
|
Loestrin
|
Menzol
|
Microneth
|
Micronett
|
Micronor
|
Micronovum
|
Milli
|
Mini-Pe
|
Mini-Pill
|
Minovlar
|
Modicon
|
N.E.E.
|
NET
|
Necon
|
Nelova
|
Neocon
|
Nodiol
|
Nor-Q.D.
|
Nor-Qd
|
Noraethisteronum
|
Noralutin
|
Norcept
|
Norcept-E
|
Norcolut
|
Noresthisterone
|
Norethadrone
|
Norethin
|
Norethin 1/35 E
|
Norethin 1/50 M
|
Norethindrone Acetate
|
Norethindrone Norethisterone
|
Norethisteron
|
Norethisterone
|
Norethisterone [Progestins]
|
Norethisteronum [INN-Latin]
|
Norethyndron
|
Norethynodron
|
Norethynodrone
|
Noretisterona [INN-Spanish]
|
Noretisterone [Dcit]
|
Norfor
|
Norgestin
|
Noriday
|
Noriday 28
|
Norimin
|
Norinyl
|
Norlestrin
|
Norlutate
|
Norluten
|
Norlutin
|
Norluton
|
Normapause
|
Norpregneninlone
|
Norpregneninolone
|
Norpregneninotone
|
Orlest
|
Ortho 1 35
|
Ortho 7 7 7
|
Ortho-Novum
|
Ortho-Novum 1 35
|
Ortho-Novum 1 50
|
Ortho-Novum 7 7 7
|
Ovcon
|
Ovysmen
|
Ovysmen 0.5 35
|
Ovysmen 1 35
|
Palonyl
|
Perovex
|
Primolut N
|
Primolut-N
|
Proluteasi
|
Synphase
|
Synphasic 28
|
Tri-Norinyl
|
Triella
|
Trinovum
|
Trinovum 21
|
Utovlan
|
Utovlar
|
Loestrin 24 Fe
|
|
|
Synonyms
|
Norethindrone
|
19-Norethindrone
|
17α-Ethynyl-19-nortestosterone
|
17-Hydroxy-19-nor-17α-4-pregnen-20-yn-3-one
|
17α-Ethynyl-17β-hydroxy-19-nor-4-androsten-3-one
|
19-Nor-17α-ethynyl-4-androsten-17β-ol-3-one
|
19-Norethisterone
|
(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
|
17α-Ethynyl-17 β-hydroxy-19-nor-4-androsten-3-one
|
17α-Ethynyl-19-nortestosterone
|
17α-乙炔基-19-去甲睾酮
|
17-羟基-19-去甲-17α-孕甾-4-烯-20-炔基-3-酮
|
17α-乙炔基-17β-羟基-19-去甲-4-雄甾烯-3-酮
|
19-去甲-17α-乙炔基-4-雄甾烯-17β-醇-3-酮
|
去甲基脱氢羟孕酮
|
炔诺酮
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
17.594933
|
H Acceptors
|
2
|
H Donor
|
1
|
LogD (pH = 5.5)
|
3.217228
|
LogD (pH = 7.4)
|
3.217228
|
Log P
|
3.217228
|
Molar Refractivity
|
87.4245 cm3
|
Polarizability
|
34.003754 Å3
|
Polar Surface Area
|
37.3 Å2
|
Rotatable Bonds
|
0
|
Lipinski's Rule of Five
|
true
|
Log P
|
2.72
|
LOG S
|
-4.65
|
Solubility (Water)
|
6.68e-03 g/l
|
PROPERTIES
PROPERTIES
Physical Property
Safety Information
Pharmacology Properties
Product Information
Bioassay(PubChem)
Solubility
|
7.04 mg/L
|
Show
data source
|
chloroform: ≥50 mg/mL, clear, colorless
|
Show
data source
|
|
Apperance
|
white to off-white powder
|
Show
data source
|
|
Melting Point
|
203-204 °C
|
Show
data source
|
205-206 °C(lit.)
|
Show
data source
|
|
Optical Rotation
|
[α]20/D -24°, c = 1 in chloroform
|
Show
data source
|
|
Hydrophobicity(logP)
|
3.2
|
Show
data source
|
|
Storage Condition
|
protect from light
|
Show
data source
|
Room Temperature (15-30°C)
|
Show
data source
|
|
RTECS
|
RC8975000
|
Show
data source
|
|
European Hazard Symbols
|
Toxic (T)
|
Show
data source
|
Harmful (Xn)
|
Show
data source
|
|
MSDS Link
|
|
German water hazard class
|
3
|
Show
data source
|
|
Risk Statements
|
40
|
Show
data source
|
R:45
|
Show
data source
|
|
Safety Statements
|
22-36/37/39-45
|
Show
data source
|
S:28-36/37/39-45-53
|
Show
data source
|
|
GHS Pictograms
|
|
Show
data source
|
|
GHS Signal Word
|
Warning
|
Show
data source
|
|
GHS Hazard statements
|
H351
|
Show
data source
|
|
GHS Precautionary statements
|
P281
|
Show
data source
|
|
Personal Protective Equipment
|
dust mask type N95 (US), Eyeshields, Gloves
|
Show
data source
|
Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
|
Show
data source
|
|
Gene Information
|
human ... AR(367), PGR(5241)rat ... Ar(24208)
|
Show
data source
|
|
Purity
|
≥98%
|
Show
data source
|
98%
|
Show
data source
|
|
Grade
|
VETRANAL™, analytical standard
|
Show
data source
|
|
Certificate of Analysis
|
|
Packaging
|
vial of 250 mg
|
Show
data source
|
|
Empirical Formula (Hill Notation)
|
C20H26O2
|
Show
data source
|
|
DETAILS
DETAILS
MP Biomedicals
DrugBank
Sigma Aldrich
MP Biomedicals -
02155946
|
(17α-Ethynyl-17β-hydroxy-19-nor-4-androsten-3-one; 17α-Ethynyl-19-nortestosterone) Crystalline |
DrugBank -
DB00717
|
Item |
Information |
Drug Groups
|
approved |
Description
|
A synthetic progestational hormone with actions similar to those of progesterone but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception. [PubChem] |
Indication |
For use as an oral contraceptive in the prevention of pregnancy. |
Pharmacology |
Norethindrone is a synthetic oral progestin. It is used for contraception or to treat such conditions as secondary amenorrhea, abnormal uterine bleeding, and endometriosis. As an oral contraceptive, norethindrone is available as either a single agent or in combination with an estrogen. |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Hepatic |
Absorption |
Absolute oral bioavailability approximately 64% |
Half Life |
7 hours |
Protein Binding |
>95% |
External Links |
|
|
Sigma Aldrich -
N6384
|
Biochem/physiol Actions 炔诺酮是用于抑制细胞溶质磺基转移酶类 (SULT) 的口服避孕药。 包装 Supplied in amber screw-cap vials |
Sigma Aldrich -
N4128
|
Biochem/physiol Actions 炔诺酮是用于抑制细胞溶质磺基转移酶类 (SULT) 的口服避孕药。 包装 1, 5 g in glass bottle 250 mg in glass bottle 50 mg in poly bottle |
Sigma Aldrich -
286850
|
Biochem/physiol Actions 19-norethindrone is an oral contraceptive involved in the inhibition of cytosolic sulfotransferases (SULT). |
Sigma Aldrich -
46525
|
Biochem/physiol Actions 19-norethindrone is an oral contraceptive involved in the inhibition of cytosolic sulfotransferases (SULT). Legal Information VETRANAL is a trademark of Sigma-Aldrich Co. LLC |
PATENTS
PATENTS
PubChem Patent
Google Patent